Gerresheimer performance levels simplify choice of optimum solution

Detail - Gerresheimer AG
Gerresheimer’s new, standardized division into three different performance levels for injection vials, syringes, cartridges and ampoules makes it easier to choose the right solution.
  • Three performance levels for injection vials, syringes, ampoules and cartridges
  • Clear and consistent structure for specific requirements
  • Gx Elite offers highest performance and best protection for sensitive medications

 

Düsseldorf, April 3, 2024. Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, presents its new performance levels for injection vials, syringes, cartridges and ampoules. Within the relevant product category, customers can choose from three performance levels: Gx Value, Gx Advance and Gx Elite. The new structure makes it easier to select the right product platform according to the requirements for the pharmaceutical active agent or area of application. Gx Elite products offer the highest performance and are especially suitable for innovative biopharmaceutical products.

“We offer the right solution for all active agents, therapeutic areas and production requirements,” says Holger Krenz, Global Vice President Business Development High Value Products Tubular Glass. “The new performance levels give our customers a transparent overview of our portfolio and make it easier to select the right product.”

Clear structure helps with finding the right solution fast
By dividing its product portfolio into three performance levels – Gx Value, Gx Advance and Gx Elite – Gerresheimer has created a standardized structure for its product platforms for bulk and presterilized “ready-to-fill” primary packaging. This lets customers quickly find the right product for their application. The portfolio encompasses syringes, cartridges, ampoules and injection vials for the full spectrum of pharmaceutical applications in human and veterinary medicine, including solutions for innovative biopharmaceutical products in the areas of cell and gene therapy.

Gx Value: Proven pharmaceutical-grade products
The Gx Value product line for injection vials, syringes, ampoules and cartridges encompasses pharmaceutical-grade products made of type I borosilicate glass. Having proven their value millions of times over, these items are the point of entry for the Gerresheimer product world. Gx Value products meet all qualitative, regulatory and technical requirements. Gerresheimer produces Gx Value products worldwide for the various regional markets. With local production sites, Gerresheimer is able to ensure  high product availability and fast delivery. Gx Value solutions are used for a broad spectrum of pharmaceutical products, such as anticoagulants and anesthetics.

Gx Advance: Higher efficiency during the fill & finish process
Gx Advance injection vials, syringes, ampoules and cartridges offer all the properties of Gx Value products plus expanded product features, including e.g. enabling greater filling efficiency. This includes tighter tolerances, reduced glass-to-glass and glass-to-metal contact and higher surface quality. This enables an efficient filling process that can lower process costs. Gx Advance syringes and Gx Advance cartridges are optionally also available as ready-to-fill (RTF) products. Gx Advance solutions are typically used in large-scale industrial mass production, where they are used for items such as vaccines or active agents for diabetes treatment, such as insulin or GLP-1.

Gx Elite: Highest performance and top-notch protection for sensitive pharmaceuticals
Gx Elite injection vials, syringes and cartridges offer all of the advantages of the Gx Advance level while also providing significantly higher breakage protection, strict adherence to tolerances and maximum surface quality. This ensures a highly efficient and reliable filling process and top-notch protection for the pharmaceutical products. These product characteristics are achieved through a special production process that is gentle on the materials, with no glass-to-glass contact and minimized glass-to-metal contact. Gx Elite products are a perfect choice for pharmaceuticals with special requirements, including biopharmaceuticals such as mRNA active agents, gene therapies and applications for use in ophthalmology.

Ready-to-fill with ecofriendly sterilization
All Gx Elite products are also available presterilized in a ready-to-fill (RTF) version. Gerresheimer offers two packaging platforms for this: EZ-fill and EZ-fill Smart. Vaporized hydrogen peroxide (VHP) sterilization will also be available for the EZ-fill Smart packaging platform for the first time. This ecofriendly, resource-conserving method uses no toxic substances at all and meets the most stringent requirements set by the U.S. Food and Drug Administration (FDA). Gerresheimer is taking on a leading role by implementing VHP sterilization in the RTF manufacturing process. Customer benefits include optimized delivery times for the EZ-fill and EZ-fill Smart packaging platforms. Both RTF platforms are compatible with all standard commercially available fill & finish lines and enable a flexible, reliable and cost-effective filling process.

Complete systems and solutions
All injection vials, syringes, cartridges and ampoules at the GX Value, Advance and Elite performance levels are also available as complete systems with the suitable components. This includes a broad array of different sealing and closure solutions along with various rubber components and built-in needle protection systems for prefillable syringes. Some products are also available in special configurations, such as silicone oil-free prefillable syringes.

The new Gx performance levels are supplemented by Gx Choice, which lets customers freely configure a broad range of customer-specific product solutions.

 

About Gerresheimer 
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. With 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. With around 12,000 employees, the company generated revenues of around €2bn in 2023. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6). 

Gx®, RTF® and EZ-fill SmartTM are registered trademarks of Gerresheimer.

 

Contact Gerresheimer

Marion Stolzenwald
Senior Manager Corporate Communication
P +49 1722424185
marion.stolzenwald-remove@remove-gerresheimer.com

Jutta Lorberg
Head of Corporate Communication
P +49 211 6181 264
jutta.lorberg-remove@remove-gerresheimer.com

Contact us!

Communication & Marketing
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com

Press
Phone: +49 211 61 81 246
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com